News Related to NHS England

Related coverage linked through entity extraction aliases.

UK Puberty Blocker Trial Paused After Regulator Raises Age and Safety Concerns

Feb 22, 2026

The Pathways clinical trial into puberty blockers has been paused after the MHRA raised concerns about minimum age limits and unquantified long-term biological risks, with recruitment now suspended pending resolution.

Weight-Loss Drug Access Skews Toward Affluent Areas Despite Higher Obesity in Deprived Regions

Feb 20, 2026

Private prescriptions for GLP-1 weight-loss drugs in England are concentrated in affluent areas despite higher obesity rates in deprived regions. Online pharmacies face scrutiny for inadequate verification checks when dispensing these medications.